1
|
Knoben JE. Drug utilization review. Current status and relationship to assuring quality medical care. DRUG INTELLIGENCE & CLINICAL PHARMACY 1976; 10:222-8. [PMID: 10236237 DOI: 10.1177/106002807601000405] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Drug utilization is expected to increase in the years ahead, thereby fostering the use of cost control and quality assurance mechanisms in the form of drug utilization/peer review. An overview of the current status of drug utilization review (DUR) is presented, and an examination is made in terms of the relationship of DUR to assuring quality medical care. For the most part, existing drug utilization review systems are centrally based and retrospectively screen drug claims “by exception”, using quantity standards of appropriateness. The primary deficiency of current programs is the relative lack of “quality measures”, and secondarily, the need to integrate drug utilization review into the overall medical care review process. Recommendations for demonstration and research efforts are given.
Collapse
|